Form 8-K

8-K — FIREFLY NEUROSCIENCE, INC.

Accession: 0001213900-26-099733

Filed: 2026-09-14

Period: 2026-09-08

CIK: 0000803578

SIC: 7372 (SERVICES-PREPACKAGED SOFTWARE)

Item: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Item: Financial Statements and Exhibits

Documents

8-K — ea0305233-8k_firefly.htm (Primary)

EX-10.1 — OFFER OF EMPLOYMENT, DATED JULY 28, 2026, BETWEEN FIREFLY NEUROSCIENCE, INC. AND JESSICA PAZ (ea030523301ex10-1.htm)

EX-10.3 — EMPLOYEE CONFIDENTIAL INFORMATION AND INVENTIONS ASSIGNMENT AGREEMENT, DATED AS OF SEPTEMBER 9, 2026, BETWEEN FIREFLY NEUROSCIENCE, INC. AND JESSICA PAZ (ea030523301ex10-3.htm)

GRAPHIC (ea030523301_ex10-1img1.jpg)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — CURRENT REPORT

8-K (Primary)

Filename: ea0305233-8k_firefly.htm · Sequence: 1

false

0000803578

2026-09-08

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities

Exchange Act of 1934

Date of Report (Date of earliest event reported):

September 8, 2026

FIREFLY NEUROSCIENCE, INC.

(Exact name of registrant as specified in its charter)

Delaware

001-41092

54-1167364

(State or other jurisdiction

of incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

1100 Military Road, Kenmore, NY

14217

(Address of principal executive offices)

(Zip Code)

(888) 237-6412

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K

filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.0001 per share

AIFF

The Nasdaq Capital Market

Indicate by check

mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities

Exchange Act of 1934.

Emerging Growth Company ☐

If an emerging growth company, indicate by check

mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting

standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of

Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On September 8, 2026, the board of directors (the

“Board”) of Firefly Neuroscience, Inc., a Delaware corporation (the “Company”), terminated Paul Krzywicki as Chief

Financial Officer of the Company, effective September 24, 2026. Mr. Krzywicki’s termination was not the result of any disagreement

with the Company on any matter relating to the Company’s operations, policies or practices. On the same date, the Nominating and

Corporate Governance Committee of the Board recommended the appointment of Jessica Paz as Chief Accounting Officer of the Company, and

the Board approved Ms. Paz’s appointment as Chief Accounting Officer of the Company.

On September 8, 2026, the Compensation Committee

of the Board approved and ratified an offer of employment extended to Ms. Paz, dated July 28, 2026 (the “Paz Offer of Employment”).

Under the Paz Offer of Employment, Ms. Paz was employed as the Company’s Chief Accounting Officer effective September 8, 2026, at

an annual base salary of $215,000. Pursuant to the Paz Offer of Employment, Ms. Paz was granted a stock option to purchase 50,000 shares

of common stock of the Company under the Firefly Neuroscience, Inc. 2024 Long-Term Incentive Plan (as amended, the “Plan”)

and the form of the stock option agreement approved for grants under the Plan, at an exercise price per share equal to the fair market

value of the Company’s common stock on the date of grant. The option will vest over four years, with 25% of the shares vesting on

the first anniversary of Ms. Paz’s vesting commencement date and the remaining shares vesting in equal quarterly installments over

the following twelve quarters, subject to her continued employment with the Company through each applicable vesting date. Ms. Paz will

be eligible to participate in the Company’s standard benefits covering employees at her level and will receive paid time off pursuant

to the Company’s flexible PTO policy. Ms. Paz’s employment is at-will.

Under an Indemnification Agreement between the

Company and Ms. Paz in the Company’s standard form for officers or directors of the Company, dated as of September 8, 2026 (the

“Paz Indemnification Agreement”), the Company agreed to indemnify Ms. Paz to the fullest extent permitted by applicable law

against expenses, losses, liabilities, judgments, fines, penalties and amounts paid in settlement incurred by Ms. Paz in connection with

any proceeding relating to her service as an officer of the Company. The Company will also advance all expenses incurred by Ms. Paz in

connection with any such proceeding within twenty (20) days after receipt of Ms. Paz’s written request therefor, without regard

to whether Ms. Paz will ultimately be entitled to be indemnified for such expenses. Any obligation to repay advances will be unsecured

and interest-free. The Paz Indemnification Agreement also provides that if the Company or any of its subsidiaries maintains a directors’

and officers’ liability insurance policy, Ms. Paz will be covered by such policy in such a manner as to provide her the same rights

and benefits as are accorded to the most favorably insured of the Company’s and its subsidiaries’ then current directors and

officers.

Ms. Paz and the Company also entered into

an Employee Confidential Information and Inventions Assignment Agreement, dated as of September 9, 2026 (the “Paz Confidentiality

Agreement”), which prohibits unauthorized use or disclosure of the Company’s proprietary information, and contains a general

assignment of rights to inventions and intellectual property rights, non-competition provisions that apply during the term of employment,

non-solicitation provisions that apply during the term of employment and for one year after the term of employment, and non-disparagement

provisions that apply during and after the term of employment.

The foregoing summary of the terms and conditions

of the Paz Offer of Employment, the Paz Indemnification Agreement, and the Paz Confidentiality Agreement does not purport to be complete

and is qualified in its entirety by reference to the full text of each of the Paz Offer of Employment, the Paz Indemnification Agreement,

and the Paz Confidentiality Agreement filed as Exhibit 10.1, Exhibit 10.2, and Exhibit 10.3 to this report, respectively, which is incorporated

herein by reference.

Ms. Paz, 46, most recently served as Senior Director

of Accounting and Operations at Genvid Holdings, Inc., a technology company, from April 2020 to August 2026. From February 2019 to April

2020, Ms. Paz served as Global Financial Controller at VITECH Systems Group, Inc. From September 2016 to November 2018, Ms. Paz served

as North America Controller, Global Payment Solutions at Finastra (formerly D+H Corporation). Earlier in her career, Ms. Paz held finance

and accounting leadership positions at PEN American Center, Pro Mujer International Inc., Reboot Holdings Pty Ltd., and Kaplan, Inc. Ms.

Paz holds a Master of Science in Accounting and Finance and a Master of Business Administration in Technology Management, each from SUNY

Polytechnic Institute, and a Bachelor of Science in Accounting from Hunter College, City University of New York.

There are no family relationships among Ms. Paz

and any of the Company’s other executive officers or directors. There are and have been no transactions in which Ms. Paz has an

interest requiring disclosure under Item 404(a) of Regulation S-K.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.

Description

10.1

Offer of Employment, dated July 28, 2026, between Firefly Neuroscience, Inc. and Jessica Paz,

10.2

Form of Indemnification Agreement between Firefly Neuroscience, Inc. and each executive officer or director (incorporated herein by reference to Exhibit 10.8 to the Company’s Current Report on Form 8-K, filed with the SEC on August 12, 2024).

10.3

Employee Confidential Information and Inventions Assignment Agreement, dated as of September 9, 2026, between Firefly Neuroscience, Inc. and Jessica Paz

104

Cover Page Interactive Data File (embedded with the Inline XBRL document).

SIGNATURES

Pursuant to the requirements

of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto

duly authorized.

Date: September 14, 2026

FIREFLY NEUROSCIENCE, INC.

/s/ Greg Lipschitz

Name:

Greg Lipschitz

Title:

Chief Executive Officer

EX-10.1 — OFFER OF EMPLOYMENT, DATED JULY 28, 2026, BETWEEN FIREFLY NEUROSCIENCE, INC. AND JESSICA PAZ

EX-10.1

Filename: ea030523301ex10-1.htm · Sequence: 2

Exhibit 10.1

Offer of Employment

July 28, 2026

Dear Jessica L Paz,

On behalf of Firefly Neuroscience

Inc (the “Company”), I am pleased to invite you to join the Company in the role of “Chief Accounting Officer”.

In this position, you will be expected to devote your full business time, attention and energy to the performance of your duties with

the Company. The effective date of your employment will be September 8, 2026, or such other date as you and the Company mutually agree

in writing.

The terms of this offer of employment are as follows:

1. At-Will Employment. You should be aware that your employment

with the Company is for no specified period and constitutes “at-will” employment. As a result, you are free to terminate

your employment at any time, for any reason or for no reason. Similarly, the Company is free to terminate your employment at any time,

for any reason or for no reason. We request that you give the Company at least two weeks’ notice in the event of a resignation.

2. Compensation. The Company will pay you a base salary of $215,000

per year payable in accordance with the Company’s standard payroll policies, including compliance with applicable withholding.

Subject to Board approval, you will also be granted an option to purchase 50,000 shares of the Company’s common stock under the

Company’s equity incentive plan and standard stock option agreement. The exercise price per share will be equal to the fair market

value of the Company’s common stock on the date of grant. The option will vest over four (4) years, with twenty-five percent (25%)

of the shares vesting on the first anniversary of your vesting commencement date and the remaining shares vesting in equal quarterly

installments over the following twelve (12) quarters, subject to your continued employment with the Company through each applicable vesting

date. Please note that the Company may modify job titles, compensation, and benefits from time to time as it deems necessary.

3. PTO. You will be eligible to Paid Time Off (PTO) through

Firefly’s flexible PTO policy, where you can take time off as you need provided you obtain consent from your manager. Firefly also

has a standard calendar of paid company holidays.

4. Benefits. During the term of your employment, you will be

entitled to the Company’s standard benefits covering employees at your level, as such may be in effect from time to time.

1100 Military Road, Buffalo, New York 14217

5. Background Checks. The Company reserves the right to conduct

background investigations and/or reference checks on all of its potential employees. Your job offer is contingent upon your clearance

of any such background investigation and/or reference check.

6. Immigration Laws. For purposes of federal immigration laws,

you will be required to provide to the Company documentary evidence of your identity and eligibility for employment in the United States.

Such documentation must be provided within 3 business days of the effective date of your employment, or your employment relationship

with the Company may be terminated.

7. Prior Obligations; Conflicting Obligations; Third Party Information.

If you have not already done so, please disclose to the Company whether there are any agreements relating to your prior employment or

provision of services which may affect your ability to be employed by the Company or limit the manner in which you may be employed. During

your employment with the Company, you agree not to engage in any other employment, consulting, or business activity that is directly

related to the business of the Company as conducted during your employment, and not to engage in any other activities that conflict with

your obligations to the Company. You also agree not to bring any third-party confidential information to the Company, including that

of your former employer, and that you will not use any such information during the course of your employment with the Company.

8. Employee Proprietary Information Agreement. As a condition

of this offer of employment, you will be required to complete, sign and return the Company’s standard form of Employee Proprietary

Information Agreement (the “EPIA”).

9. Employee Policies. As a Company employee, you will be expected

to abide by the Company’s rules and standards, as may be in effect from time to time. Specifically, you will be required to sign

an acknowledgment that you have reviewed and understand the Company’s Employee Handbook.

10. General. This offer letter and the EPIA, when signed by you,

set forth the terms of your employment with the Company and supersede any and all prior representations and agreements, including, but

not limited to, any representations made during your recruitment, interviews, or pre-employment negotiations, whether written or oral.

In the event of a conflict between the terms and provisions of this offer letter and the EPIA and the stock option agreement, the terms

and provisions of the EPIA and the stock option agreement will control. Any amendment to this offer letter or any waiver of a right under

this offer letter must be signed in writing by you and an officer of the Company. Delaware law will govern this offer letter.

1100 Military Road, Buffalo, New York 14217

We look forward to you joining the Company. If the foregoing

terms are agreeable, please indicate your acceptance by signing this offer letter in the space provided below.

Sincerely,

By:

/s/ Greg Lipschitz

Name:

Greg Lipschitz

Title:

CEO

AGREED TO AND ACCEPTED:

By:

/s/ Jessica L. Paz

Name:

Jessica L. Paz

1100 Military Road, Buffalo, New York 14217

EX-10.3 — EMPLOYEE CONFIDENTIAL INFORMATION AND INVENTIONS ASSIGNMENT AGREEMENT, DATED AS OF SEPTEMBER 9, 2026, BETWEEN FIREFLY NEUROSCIENCE, INC. AND JESSICA PAZ

EX-10.3

Filename: ea030523301ex10-3.htm · Sequence: 3

Exhibit 10.3

EMPLOYEE CONFIDENTIAL INFORMATION

AND INVENTIONS ASSIGNMENT AGREEMENT

In consideration

of my employment or continued employment by FIREFLY NEUROSCIENCE, INC., a Delaware corporation (“Company”),

and the compensation being paid or to be paid to me during my employment with Company, I agree to the terms of this Agreement as follows:

Confidential Information Protections.

Nondisclosure; Recognition of

Company’s Rights. At all times during and after my employment, I will hold in confidence and will not disclose, use,

lecture upon, or publish any of Company’s Confidential Information (defined below), except (i) as may be required in

connection with my work for Company, (ii) as expressly authorized by an authorized officer of Company at the direction of

the Board of Directors of Company; or (iii) as required or permitted to be disclosed pursuant to Rule 21F-17(a) under the Securities

Exchange Act of 1934, as amended, or other applicable law, legal process or government regulation, provided, however, that prior to

any disclosure of confidential information as required by such applicable law, I shall, to the extent such applicable law so

permits, use my best efforts to advise Company in advance of my making any such permitted or required disclosure and cooperate with

Company in order to afford Company a reasonable opportunity to take any legally-permissible actions to contest, limit, remove the

basis for, or otherwise address such disclosure in connection with my work for Company. Except as provided above, I will obtain the

written approval of an authorized officer of the Company before publishing or submitting for publication any material (written,

oral, or otherwise) that relates to my work at the Company and/or incorporates any Confidential Information. Except as otherwise

provided by applicable law I hereby assign to the Company any rights I may have or acquire in any and all Confidential Information

and recognize that all Confidential Information shall be the sole and exclusive property of the Company and its assigns.

1.2

Confidential Information. The term “Confidential Information” shall mean any and all confidential knowledge,

data or information related to Company’s business or its actual or demonstrably anticipated research or development, including

without limitation (a) trade secrets, inventions, ideas, processes, computer source and object code, data, formulae, programs, other

works of authorship, know-how, improvements, discoveries, developments, designs, and techniques; (b) information regarding products,

services, plans for research and development, marketing and business plans, budgets, financial statements, contracts, prices, suppliers,

and customers; (c) information regarding the skills and compensation of Company’s employees, contractors, and any other service

providers of Company; and (d) the existence of any business discussions, negotiations, or agreements between Company and any third party.

1.3 Third Party Information. I

understand that Company has received and, in the future, will receive from third parties confidential or proprietary information

(“Third Party Information”) subject to a duty on Company’s part to maintain the confidentiality of

such information and to use it only for certain limited purposes. During and after the term of my employment, I will hold Third

Party Information in strict confidence and will not disclose to anyone (other than Company personnel who need to know such

information in connection with their work for Company) or use Third Party Information, except in connection with my work for Company

or unless expressly authorized by an officer of Company in writing.

1.4 No

Improper Use of Information of Prior Employers and Others. I represent that my employment by Company does not and will not breach

any agreement with any former employer, including any noncompete agreement or any agreement to keep in confidence or refrain from using

information acquired by me prior to my employment by Company. I further represent that I have not entered into, and will not enter into,

any agreement, either written or oral, in conflict with my obligations under this Agreement. During my employment by Company, I will not

improperly make use of, or disclose, any information or trade secrets of any former employer or other third party, nor will I bring onto

the premises of Company or use any unpublished documents or any property belonging to any former employer or other third party, in violation

of any lawful agreements with that former employer or third party. I will use in the performance of my duties only information that is

generally known and used by persons with training and experience comparable to my own, is common knowledge in the industry or otherwise

legally in the public domain or is otherwise provided or developed by Company.

Inventions.

2.1

Definitions. As used in this Agreement, the term “Invention” means any ideas, concepts, information, materials,

processes, data, programs, know-how, improvements, discoveries, developments, designs, artwork, formulae, other copyrightable works,

and techniques and all Intellectual Property Rights in any of the items listed above. The term “Intellectual Property Rights”

means all trade secrets, copyrights, trademarks, mask work rights, patents and other intellectual property rights recognized by the

laws of any jurisdiction or country. The term “Moral Rights” means all paternity, integrity, disclosure, withdrawal,

special and any other similar rights recognized by the laws of any jurisdiction or country.

2.2

Prior Inventions. I have disclosed on Exhibit A a complete list of all Inventions that (a) I have, or I have caused to be,

alone or jointly with others, conceived, developed, or reduced to practice prior to the commencement of my employment by Company; (b)

in which I have an ownership interest or which I have a license to use; (c) and that I wish to have excluded from the scope of this Agreement

(collectively referred to as “Prior Inventions”). If no Prior Inventions are listed in Exhibit A or

if I have not completed Exhibit A, I warrant that there are no Prior Inventions. I agree that I will not incorporate, or permit

to be incorporated, Prior Inventions in any Company Inventions (defined below) without Company’s prior written consent. If, in

the course of my employment with Company, I incorporate a Prior Invention into a Company process, machine or other work, I hereby grant

Company a non-exclusive, perpetual, fully-paid and royalty-free, irrevocable and worldwide license, with rights to sublicense through

multiple levels of sublicensees, to reproduce, make derivative works of, distribute, publicly perform, and publicly display in any form

or medium, whether now known or later developed, make, have made, use, sell, import, offer for sale, and exercise any and all present

or future rights in, such Prior Invention.

2.3 Assignment

of Company Inventions. Inventions assigned to Company or to a third party as directed by Company pursuant to the subsection

titled Government or Third Party are referred to in this Agreement as “Company Inventions.” Subject to the

subsection titled Government or Third Party and except for Inventions that I can prove qualify fully under the provisions of

California Labor Code section 2870 and I have set forth in Exhibit A, I hereby assign and agree to assign in the future (when

any such Inventions or Intellectual Property Rights are first reduced to practice or first fixed in a tangible medium, as

applicable) to Company all my right, title, and interest in and to any and all Inventions (and all Intellectual Property Rights with

respect thereto) made, conceived, reduced to practice, or learned by me, either alone or with others, during the period of my

employment by Company. Any assignment of Inventions (and all Intellectual Property Rights with respect thereto) hereunder includes

an assignment of all Moral Rights. To the extent such Moral Rights cannot be assigned to Company and to the extent the following is

allowed by the laws in any country where Moral Rights exist, I hereby unconditionally and irrevocably waive the enforcement of such

Moral Rights, and all claims and causes of action of any kind against Company or related to Company’s customers, with respect

to such rights. I further acknowledge and agree that neither my successors-in- interest nor legal heirs retain any Moral Rights in

any Inventions (and any Intellectual Property Rights with respect thereto).

2.4 Obligation

to Keep Company Informed. During the period of my employment and for one (1) year after my employment ends, I will promptly and

fully disclose to Company in writing (a) all Inventions authored, conceived, or reduced to practice by me, either alone or with

others, including any that might be covered under California Labor Code section 2870, and (b) all patent applications filed by me or

in which I am named as an inventor or co-inventor.

2.5 Government

or Third Party. I agree that, as directed by Company, I will assign to a third party, including without limitation the United States,

all my right, title, and interest in and to any particular Company Invention.

2.6 Enforcement

of Intellectual Property Rights and Assistance. During and after the period of my employment and at Company’s request and

expense, I will assist Company in every proper way, including consenting to and joining in any action, to obtain and enforce United

States and foreign Intellectual Property Rights and Moral Rights relating to Company Inventions in all countries. I will execute any

documents that the Company may reasonably request for use in obtaining or enforcing such Intellectual Property Rights and Moral

Rights. My obligations under this paragraph will continue beyond the termination of my employment with the Company, provided that

Company will compensate me at a reasonable rate after such termination for time or expenses actually spent by me at Company’s

request on such assistance.

2.7 Incorporation

of Software Code. I agree that I will not incorporate into any Company software or otherwise deliver to Company any software code

licensed under the GNU General Public License or Lesser General Public License or any other license that, by its terms, requires or conditions

the use or distribution of such code on the disclosure, licensing, or distribution of any source code owned or licensed by Company except

as expressly authorized by Company or in strict compliance with Company’s policies regarding the use of such software.

Records. I agree to keep and maintain adequate and current records (in the form of

notes, sketches, drawings and in any other form that is required by Company) of all Inventions made by me during the period of my employment

by Company, which records shall be available to, and remain the sole property of, Company at all times.

4. Additional

Activities. I agree that I will not (a) during the term of my employment by Company, without Company’s express written

consent, engage in any employment or business activity that is competitive with, or would otherwise conflict with my employment by, Company;

and (b) during the term of my employment by Company and for one (1) year thereafter, I will not either directly or indirectly, solicit

or attempt to solicit any employee, independent contractor, or consultant of Company to terminate his, her or its relationship with Company

in order to become an employee, consultant, or independent contractor to or for any other person or entity. Furthermore, I agree that

during the term of my employment by the Company and thereafter, I shall not disparage Company, any officer or director of Company or any

affiliate or agent of Company.

5. Return

Of Company Property. Upon termination of my employment or upon Company’s request at any other time, I will deliver

to Company all of Company’s property, equipment, and documents, together with all copies thereof, and any other material

containing or disclosing any Inventions, Third Party Information or Confidential Information and certify in writing that I have

fully complied with the foregoing obligation. I agree that I will not copy, delete, or alter any information contained upon my

Company computer or Company equipment before I return it to the Company. In addition, if I have used any personal computer, server,

or e-mail system to receive, store, review, prepare or transmit any Company information, including but not limited to, Confidential

Information, I agree to provide the Company with a computer-useable copy of all such Confidential Information and then permanently

delete and expunge such Confidential Information from those systems; and I agree to provide Company access to my system as

reasonably requested to verify that the necessary copying and/or deletion is completed. I further agree that any property situated

on Company’s premises and owned by Company is subject to inspection by Company’s personnel at any time with or without

notice. Prior to the termination of my employment or promptly after termination of my employment, I will cooperate with Company in

attending an exit interview and certify in writing that I have complied with the requirements of this section.

6. Notification

Of New Employer. If I leave the employ of Company, I consent to the notification of my new employer of my rights and

obligations under this Agreement, by Company providing a copy of this Agreement or otherwise.

General Provisions.

7.1

Governing Law and Venue. This Agreement and any action related thereto will be governed and interpreted by and under the laws of

the State of Delaware, without giving effect to any conflicts of laws principles that require the application of the law of a different

state. I expressly consent to personal jurisdiction and venue in the state and federal courts for the county in which Company’s

principal place of business is located for any lawsuit filed there against me by Company arising from or related to this Agreement.

7.2 Severability.

If any provision of this Agreement is, for any reason, held to be invalid or unenforceable, the other provisions of this Agreement

will remain enforceable, and the invalid or unenforceable provision will be deemed modified so that it is valid and

enforceable to the maximum extent permitted by law.

7.3

Survival. This Agreement shall survive the termination of my employment and the assignment of this Agreement by Company

to any successor or other assignee and shall be binding upon my heirs and legal representatives.

7.4 Employment.

I agree and understand that nothing in this Agreement shall give me any right to continued employment by Company, and it will not interfere

in any way with my right or Company’s right to terminate my employment at any time, with or without cause and with or without advance

notice.

7.5 Notices.

Each party must deliver all notices or other communications required or permitted under this Agreement in writing to the other party

at the address listed on the signature page, by courier, by certified or registered mail (postage prepaid and return receipt

requested), or by a nationally- recognized express mail service. Notice will be effective upon receipt or refusal of delivery. If

delivered by certified or registered mail, notice will be considered to have been given five (5) business days after it was mailed,

as evidenced by the postmark. If delivered by courier or express mail service, notice will be considered to have been given on the

delivery date reflected by the courier or express mail service receipt. Each party may change its address for receipt of notice by

giving notice of the change to the other party.

7.6 Injunctive

Relief. I acknowledge that, because my services are personal and unique and because I will have access to the Confidential Information

of Company, any breach of this Agreement by me would cause irreparable injury to Company for which monetary damages would not be an adequate

remedy and, therefore, will entitle Company to injunctive relief (including specific performance). The rights and remedies provided to

each party in this Agreement are cumulative and in addition to any other rights and remedies available to such party at law or in equity.

7.7 Waiver.

Any waiver or failure to enforce any provision of this Agreement on one occasion will not be deemed a waiver of that provision or any

other provision on any other occasion.

7.8 Export.

I agree not to export, reexport, or transfer, directly or indirectly, any U.S. technical data acquired from Company or any products utilizing

such data, in violation of the United States export laws or regulations.

7.9 Counterparts.

This Agreement may be executed in one or more counterparts, each of which shall be deemed an original and all of which shall be taken

together and deemed to be one instrument.

7.10 Entire

Agreement. If no other agreement governs nondisclosure and assignment of inventions during any period in which I was previously employed

or am in the future employed by Company as an independent contractor, the obligations pursuant to sections of this Agreement titled Confidential

Information Protections and Inventions shall apply. This Agreement is the final, complete and exclusive agreement of the parties with

respect to the subject matter hereof and supersedes and merges all prior communications between us with respect to such matters. No modification

of or amendment to this Agreement, or any waiver of any rights under this Agreement, will be effective unless in writing and signed by

me and an authorized officer of the Company. Any subsequent change or changes in my duties, salary or compensation will not affect the

validity or scope of this Agreement.

This Agreement shall be effective as of the first day of

my employment with Company.

COMPANY:

FIREFLY NEUROSCIENCE, INC.

By:

/s/ Greg Lipschitz

Name:

Greg Lipschitz

Title:

Chief Executive Officer

Address:

1100 Military Road, Kenmore, NY

EMPLOYEE:

HAVE READ, UNDERSTAND, AND ACCEPT THIS AGREEMENT AND HAVE BEEN GIVEN THE OPPORTUNITY TO REVIEW IT WITH INDEPENDENT LEGAL COUNSEL.

/s/ Jessica Paz

(Signature)

Jessica Paz

Name (Please Print)

9/9/2026

Address

EXHIBIT A

INVENTIONS

1. Prior Inventions

Disclosure. The following is a complete list of all Prior Inventions (as provided in Subsection 2.2 of the attached Employee Confidential

Information and Inventions Assignment Agreement):

☒ None

☐ See immediately below:

GRAPHIC

Filename: ea030523301_ex10-1img1.jpg · Sequence: 4

Binary file (3344 bytes)

Download ea030523301_ex10-1img1.jpg

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 9

v3.26.3

Cover

Sep. 08, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

Sep. 08, 2026

Entity File Number

001-41092

Entity Registrant Name

FIREFLY NEUROSCIENCE, INC.

Entity Central Index Key

0000803578

Entity Tax Identification Number

54-1167364

Entity Incorporation, State or Country Code

Entity Address, Address Line One

1100 Military Road

Entity Address, City or Town

Kenmore

Entity Address, State or Province

Entity Address, Postal Zip Code

14217

City Area Code

888

Local Phone Number

237-6412

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common Stock, par value $0.0001 per share

Trading Symbol

AIFF

Security Exchange Name

NASDAQ

Entity Emerging Growth Company

false

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration